Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €62.56 EUR
Change Today +2.63 / 4.39%
Volume 0.0
8AK On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 1:28 PM 07/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Gordon G. Pugh

Chief Operating Officer, Chief Risk Officer and Senior Vice President, Alkermes plc
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

57--

Background*

Mr. Gordon G. Pugh has been the Chief Operating Officer and Senior Vice President of Alkermes Plc (Alkermes Inc.) since May 22, 2007 and its Chief Risk Officer since September 2011. Mr. Pugh is responsible for leading all areas related to the quality manufacture of products, management of supply chains and operation of Alkermes sites. Mr. Pugh served as Vice President of Operations at Alkermes Plc since 2002. He has BS in Microbiology from Cornell University and an MBA ...

Read Full Background

Corporate Headquarters*

Connaught House
Dublin, Co. Dublin 4

Ireland

Phone: 353 1 772 8000
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BS
Cornell University
MBA
Northeastern University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
8AK:GR €62.56 EUR +2.63

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Herve Hoppenot Chief Executive Officer, President, Director and Member of Non-Management Stock Option Committee
Incyte Corporation
$2.9M
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
$620.1K
George Frederick Wilkinson Chief Executive Officer, President and Director
Impax Laboratories Inc.
$552.5K
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$830.0K
Vinita Gupta Chief Executive Officer, Executive Director and Member of Risk Management Committee
Lupin Limited
--
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALKERMES PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.